These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8154932)

  • 1. Bone turnover in non-steroid treated rheumatoid arthritis.
    Compston JE; Vedi S; Croucher PI; Garrahan NJ; O'Sullivan MM
    Ann Rheum Dis; 1994 Mar; 53(3):163-6. PubMed ID: 8154932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced bone formation in non-steroid treated patients with rheumatoid arthritis.
    Compston JE; Vedi S; Mellish RW; Croucher P; O'Sullivan MM
    Ann Rheum Dis; 1989 Jun; 48(6):483-7. PubMed ID: 2742402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic bone changes accompanying early rheumatoid arthritis in patients treated with nonsteroidal antiinflammatory drugs alone.
    Pitt P; Compston J; Trivedi P; Salisbury J; Berry H; Moniz C; Parsons V
    Clin Orthop Relat Res; 1994 Jan; (298):250-8. PubMed ID: 8118983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
    Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
    Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy.
    Cortet B; Flipo RM; Pigny P; Duquesnoy B; Racadot A; Boersma A; Delcambre B
    Rev Rhum Engl Ed; 1997 Mar; 64(3):153-9. PubMed ID: 9090763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of cartilage and bone markers after intra-articular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritis.
    Weitoft T; Larsson A; Saxne T; Rönnblom L
    Ann Rheum Dis; 2005 Dec; 64(12):1750-3. PubMed ID: 15843449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal trabecular bone mineral content in patients with non-steroid treated rheumatoid arthritis.
    Compston JE; Crawley EO; Evans C; O'Sullivan MM
    Ann Rheum Dis; 1988 Aug; 47(8):660-4. PubMed ID: 3415365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iliac crest trabecular bone mass and structure in patients with non-steroid treated rheumatoid arthritis.
    Mellish RW; O'Sullivan MM; Garrahan NJ; Compston JE
    Ann Rheum Dis; 1987 Nov; 46(11):830-6. PubMed ID: 3426289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is bone turnover a determinant of bone mass in rheumatoid arthritis?
    Cortet B; Flipo RM; Pigny P; Duquesnoy B; Boersma A; Marchandise X; Delcambre B
    J Rheumatol; 1998 Dec; 25(12):2339-44. PubMed ID: 9858427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celecoxib, a selective cyclooxygenase-2 inhibitor, reduces level of a bone resorption marker in postmenopausal women with rheumatoid arthritis.
    Tsuji S; Tomita T; Nakase T; Hamada M; Kawai H; Yoshikawa H
    Int J Rheum Dis; 2014 Jan; 17(1):44-9. PubMed ID: 24472266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between the lengths of individual osteoid seams and resorption cavities in human iliac crest cancellous bone.
    Yamaguchi K; Croucher PI; Compston JE
    Bone Miner; 1993 Oct; 23(1):27-33. PubMed ID: 8274877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritis.
    Szentpetery A; McKenna MJ; Murray BF; Ng CT; Brady JJ; Morrin M; Radovits B; Veale DJ; Fitzgerald O
    J Rheumatol; 2013 May; 40(5):653-62. PubMed ID: 23457381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for interrupted bone resorption in human iliac cancellous bone.
    Croucher PI; Gilks WR; Compston JE
    J Bone Miner Res; 1995 Oct; 10(10):1537-43. PubMed ID: 8686510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy.
    Cortet B; Flipo RM; Blanckaert F; Duquesnoy B; Marchandise X; Delcambre B
    Rev Rhum Engl Ed; 1997; 64(7-9):451-8. PubMed ID: 9338926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total and peripheral bone mass in patients with psoriatic arthritis and rheumatoid arthritis.
    Reid DM; Kennedy NS; Nicoll J; Smith MA; Tothill P; Nuki G
    Clin Rheumatol; 1986 Sep; 5(3):372-8. PubMed ID: 3780144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of low dose methotrexate on markers of bone metabolism in patients with rheumatoid arthritis.
    El Miedany YM; Abubakr IH; El Baddini M
    J Rheumatol; 1998 Nov; 25(11):2083-7. PubMed ID: 9818648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone abnormalities in the surgical treatment of patients with rheumatoid arthritis.
    Bogoch ER; Moran EL
    Clin Orthop Relat Res; 1999 Sep; (366):8-21. PubMed ID: 10627713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical markers of bone turnover in rheumatoid arthritis. Relation to anti-inflammatory treatment, sex, and menopause.
    Als OS; Riis BJ; Gotfredsen A; Christiansen C; Deftos LJ
    Acta Med Scand; 1986; 219(2):209-13. PubMed ID: 3485890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal bone remodelling in inflammatory arthritis.
    Bogoch ER; Moran E
    Can J Surg; 1998 Aug; 41(4):264-71. PubMed ID: 9711159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing glucocorticoid dosage improves serum osteocalcin in patients with rheumatoid arthritis-results from the TOMORROW study.
    Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Koike T; Nakamura H
    Osteoporos Int; 2016 Feb; 27(2):729-35. PubMed ID: 26294294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.